| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jul―01 |
An Evaluation of Prostate Cancer Screening During the COVID-19 Pandemic |
Shyam Patnaik, Danielle R Sharbaugh, Brian Chun, Daniel L. Pelzman, Robin V. Vasan, Benjamin J. Davies, Jonathan G. Yabes, Lindsay M. Sabik, Bruce L. Jacobs |
| 2 |
[GO] |
2024―Aug―13 |
The incidence of extreme serum prostate specific antigen levels during the COVID-19 pandemic |
Amanda E. Hird, Rano Matta, Refik Saskin, Erind Dvorani, Sarah Neu, Sender Herschorn, Robert K. Nam |
| 3 |
[GO] |
2024―May―29 |
Surviving the Storm: Challenges of Bladder Cancer Care During the COVID-19 Pandemic |
Caio Vinícius Suartz, Pedro Antonio Araújo Simões, Natália Doratioto Serrano Faria Braz, Flávio Rossi da Silva, Robson Uwagoya, Fernanda Masiero, Maurício Dener Cordeiro, Mateus Silva Santos Costa, Filipe de Arruda Pessoa, José Maurício Mota, William Carlos Nahas, Leopoldo Alves Ribeiro-Filho |
| 4 |
[GO] |
2023―May―05 |
Prostate-specific antigen level association with COVID-19 infection and vaccination |
Michael Frumer, Shachar Moshe Aharony, Ohad Shoshany, Daniel Kedar, Jack Baniel, Shay Golan |
| 5 |
[GO] |
2022―Nov―29 |
Evaluation of trends in treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) across Canada during the COVID-19 pandemic |
Carlos E. Stecca, Di Maria Jiang, Zachary Veitch, Sebastian J Hotte, Nimira Alimohamed, Lori Wood, Srikala S Sridhar |
| 6 |
[GO] |
2022―Nov―24 |
The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade |
Diana Taheri, Fatemeh Jahanshahi, Alireza Khajavi, Fatemeh Kafi, Alireza Pouramini, Reza Mohammadi Farsani, Yasamin Alizadeh, Maryam Akbarzadeh, Leonardo Oliveira Reis, Fatemeh Khatami, Seyed Mohammad Kazem Aghamir |
| 7 |
[GO] |
2021―Feb―18 |
The 2021 COVID-19 Artificial Intelligence Issue |
James J. Hsieh |
| 8 |
[GO] |
2021―Jan―10 |
Genitourinary medical oncology expert opinion survey regarding treatment management in COVID-19 pandemic |
Michal Sarfaty, Darren R. Feldman, Michael J. Morris, Robert J. Motzer, Dana E. Rathkopf, Ashley M. Regazzi, Gopa Iyer, Martin H. Voss, Dean F. Bajorin, Jonathan E. Rosenberg |
| 9 |
[GO] |
2020―Jul―17 |
Impact of COVID-19 pandemic on health-related quality-of-life in uro-oncologic patients: what should we wait for? |
Francesco Greco, Vincenzo Altieri, Francesco Esperto, Vincenzo Mirone, Roberto M. Scarpa |
| 10 |
[GO] |
2020―Jul―16 |
COVID-19 in patients with renal cell carcinoma in the Russian Federation |
Ilya Tsimafeyeu, Galina Alekseeva, Maria Berkut, Alexander Nosov, Igor Myslevtsev, Andrey Andrianov, Andrey Semenov, Pavel Borisov, Ruslan Zukov, Vadim Goutnik, Sergey Savchuk, Maria Volkova |
| 11 |
[GO] |
2020―Jun―22 |
Management of muscle-invasive bladder cancer during a pandemic: Impact of treatment delay on survival outcomes for patients treated with definitive concurrent chemoradiation |
Benjamin W. Fischer-Valuck, Jeff M. Michalski, Joanna G. Harton, Alison Birtle, John P. Christodouleas, Jason A. Efstathiou, Vivek K. Arora, Eric H. Kim, Eric M. Knoche, Russell K. Pachynski, Joel Picus, Yuan James Rao, Melissa Reimers, Bruce J. Roth, Paul Sargos, Zachary L. Smith, Mohamed S. Zaghloul, Hiram A. Gay, Sagar A. Patel, Brian C. Baumann |
|
